GILZ inhibits the mTORC2/AKT pathway in BCR-ABL(+) cells.
Joha S, Nugues AL, Hétuin D, Berthon C, Dezitter X, Dauphin V, Mahon FX, Roche-Lestienne C, Preudhomme C, Quesnel B, Idziorek T.
Joha S, et al. Among authors: idziorek t.
Oncogene. 2012 Mar 15;31(11):1419-30. doi: 10.1038/onc.2011.328. Epub 2011 Aug 1.
Oncogene. 2012.
PMID: 21804606
Free PMC article.